Tejara Capital LTD Chimerix Inc Transaction History

Tejara Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.91 - $1.26 $123,437 - $170,913	-135,646 Reduced 24.66%	414,430 $439 Million
Q4 2023 Feb 12, 2024	BUY	$0.9 - $1.06 $159,692 - $188,082	177,436 Added 47.62%	550,076 $529 Million
Q2 2023 Aug 11, 2023	SELL	$1.1 - $1.54 $21,690 - $30,367	-19,719 Reduced 5.03%	372,640 $451 Million
Q1 2023 May 12, 2023	BUY	$1.19 - $2.09 $77,977 - $136,951	65,527 Added 20.05%	392,359 $494 Million
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.35 $545,809 - $768,055	326,832 New	326,832 $608 Million

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $78.9M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tejara Capital LTD with notifications on news.